Abstract:Objective: To explore the method and quality control of [Formula: see text]C radiolabeled [Formula: see text]-SPD ([Formula: see text]-Stepholidine) and biodistribution of [Formula: see text]C-[Formula: see text]-SPD in vivo. Methods: (1) [Formula: see text]CO2 was produced by CTI RDS III cyclotron, converted [Formula: see text]CO2 to [Formula: see text]C–CH3I by CH3I die-block, and then converted it to [Formula: see text]C-Triflate–CH4, imported [Formula: see text]C-Triflate–CH4 to [Formula: see text]-SPD which was dissolved in Dimethyl sulfoxide [(CH3)2SO], reacted at common temperature and then obtained the product. (2) Take the sample of organs in different times 5, 15, 30, 60, 90[Formula: see text]min after injecting [Formula: see text]C-[Formula: see text]-SPD by vail in mice and measure the radioactive counts per minute (cpm), then the percent injection dose of wet tissue per gram (%ID/g) was calculated. Results: (1) The synthesis time of [Formula: see text]C-[Formula: see text]-SPD was 15 to 20[Formula: see text]min with chemical [Formula: see text]%, and PH values [Formula: see text], radiochemical [Formula: see text]% in 2[Formula: see text]h. All quality criteria of [Formula: see text]C-[Formula: see text]-SPD met the requirements of the positron radio-pharmaceuticals. (2) [Formula: see text]C-[Formula: see text]-SPD was of the characteristic that metabolism was through the liver, and kidney was the main excretory organ, which was [Formula: see text]%ID/g at 5[Formula: see text]min and was decreasing gradually, which was [Formula: see text][Formula: see text]ID/g in liver at 5[Formula: see text]min. Conclusion: (1) [Formula: see text]C-[Formula: see text]-SPD can be used to further study the animal or human. (2) [Formula: see text]C-[Formula: see text]-SPD could quickly discharge and decrease to the low level from background of issues in vivo.

Synthesis of [3‐3H]20(S)‐protopanaxadiol

Synthesis Of [3-H-3]20(S)-Protopanaxadiol

Synthesis of [3-<sup>3</sup>H]20(<i>S</i>)-protopanaxadiol

Synthesis technology of 3-n-propyl-2, 4-dihydroxyacetophenone

Radiolabeled Synthesis and Identification of A Novel Herbicide, Propyl 4-[2-(4,6-dimethoxy-2-pyrimidinyloxy)benzylamino]benzoate with All Six Benzoic Ring Carbons Labeled by C-14

Synthesis and Analysis of Two Versions of Radioisotope Carbon-14 Labelled Dufulin

Synthesis Of Carbon-14 Labeled Pyraoxystrobin, A Novel Fungicide

Synthesis and analysis of carbon-14 labelled Dufulin with high specific activity

MICROSYNTHESIS OF A NOVEL HERBICIDE, PROPYL 4-[ 2-[ (4,6-DIMETHOXY-2-PYRIMIDINYL) OXY] BENZYLAMINO] BENZOATE

Radiosynthesis of Tritium-Labeled Novel Nitromethylene Neonicotinoids Compounds with NaB3H4

Synthesis and Analysis of Carbon-14 Labelled Imidacloprid With High Specific Activity

A New Method for the Synthesis of 4-Methoxyl-2,3,5-trimethylpyridine

Synthesis and Chiral Purification of 14c‐labeled Novel Neonicotinoids, Paichongding

Improved Synthetic Approach to Tenatoprazole

Metabolic Profiles of 20(S)-Protopanaxadiol in Rats after Oral Administration Using Ultra-Performance Liquid Chromatography/quadrupole Time-of-flight Tandem Mass Spectrometry.

Restricted access magnetic core-mesoporous shell microspheres with C8-modified interior pore walls for the identification of 20(S)-protopanaxadiol metabolites in rat plasma using UPLC-Q-TOF-MS/MS

Tentative identification of 20(S)-protopanaxadiol metabolites in human plasma and urine using ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry

Preparation and Preliminary Biological Evaluation of 11C-L-spd

Preparation of 4-(2′-Methoxyethyl)phenol

Synthesis of [2-11C]5,5-dimethyl-2,4-oxazolidinedione for studies with positron tomography

The Study of Labelling of Dopamine Transporter Imaging Agent ~(99)Tc~m-Trodat-1